APG Asset Management N.V. decreased its position in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 7.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 63,776 shares of the company's stock after selling 4,873 shares during the quarter. APG Asset Management N.V. owned 0.12% of Molina Healthcare worth $19,447,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of the business. Price T Rowe Associates Inc. MD raised its position in shares of Molina Healthcare by 46.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company's stock valued at $1,264,214,000 after purchasing an additional 1,216,903 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Molina Healthcare by 74,593.7% in the 1st quarter. GAMMA Investing LLC now owns 667,015 shares of the company's stock worth $219,708,000 after purchasing an additional 666,122 shares during the last quarter. Voloridge Investment Management LLC raised its stake in shares of Molina Healthcare by 1,641.3% in the 4th quarter. Voloridge Investment Management LLC now owns 409,807 shares of the company's stock valued at $119,274,000 after purchasing an additional 386,273 shares in the last quarter. Two Sigma Investments LP bought a new position in shares of Molina Healthcare during the fourth quarter worth about $44,099,000. Finally, Nuveen LLC acquired a new position in Molina Healthcare in the first quarter worth about $46,441,000. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several equities analysts recently issued reports on the company. Wall Street Zen cut Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $210.00 price target on shares of Molina Healthcare in a report on Tuesday. Wells Fargo & Company lowered their price objective on shares of Molina Healthcare from $216.00 to $198.00 and set an "overweight" rating for the company in a research report on Friday, August 15th. Truist Financial reissued a "hold" rating and issued a $180.00 target price (down previously from $335.00) on shares of Molina Healthcare in a report on Friday, July 25th. Finally, Mizuho lowered their target price on Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating for the company in a report on Friday, July 11th. Three research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $242.91.
Get Our Latest Stock Analysis on MOH
Insider Activity at Molina Healthcare
In related news, COO James Woys bought 10,000 shares of the business's stock in a transaction dated Monday, August 4th. The shares were bought at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the transaction, the chief operating officer directly owned 74,331 shares of the company's stock, valued at approximately $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Ronna Romney sold 700 shares of the business's stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the sale, the director directly owned 17,131 shares in the company, valued at $2,633,719.94. This trade represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.10% of the company's stock.
Molina Healthcare Price Performance
Shares of NYSE MOH traded up $5.99 during mid-day trading on Friday, reaching $180.71. 1,004,098 shares of the company traded hands, compared to its average volume of 1,006,668. Molina Healthcare, Inc has a fifty-two week low of $151.95 and a fifty-two week high of $365.23. The firm has a market cap of $9.79 billion, a PE ratio of 8.89 and a beta of 0.52. The stock has a fifty day simple moving average of $201.59 and a 200-day simple moving average of $273.82. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.66 and a quick ratio of 1.66.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The firm had revenue of $11.43 billion for the quarter, compared to the consensus estimate of $10.94 billion. During the same period in the prior year, the business earned $5.86 EPS. The company's quarterly revenue was up 15.7% compared to the same quarter last year. Equities research analysts anticipate that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.